HERTFORDSHIRE, England and
PITTSBURGH, July 22, 2020 /PRNewswire/ -- Global
pharmaceutical company Mylan N.V. (NASDAQ: MYL) today
announced that it will release its second quarter 2020 financial
results on Thurs., Aug. 6, before the
open of the U.S. financial markets. The company also will host a
webcast at 10:30 a.m. ET on
Aug. 6 to discuss the results.
The briefing can be accessed live by
calling 855.493.3607 or 346.354.0950 for
international callers (ID#: 4267916) or at the following address on
the company's website: investor.mylan.com. A replay of the
webcast also will be available on the website.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a
portfolio of more than 7,500 marketed products around the world,
including antiretroviral therapies on which approximately 40% of
people being treated for HIV/AIDS globally depend. We market our
products in more than 165 countries and territories. We are one of
the world's largest producers of active pharmaceutical ingredients.
Every member of our approximately 35,000-strong workforce is
dedicated to creating better health for a better world, one person
at a time. Learn more at Mylan.com. We routinely post information
that may be important to investors on our website at
View original content to download
SOURCE Mylan N.V.